Replies to post #113 on Cadence Pharmaceuticals Inc. (CADX)

[surf1944]

7:04AM Cadence Pharma announces termination of option agreement to acquire Incline Therapeutics (CADX) 4.26 : Under the waiver, consent and option termination agreement signed by Cadence and Incline, upon the closing of the proposed acquisition of Incline by MDCO Cadence would receive a payment of ~$13 million to buy-out Cadence's interest in, and terminate Cadence's rights with respect to, the option agreement. Additionally, Cadence would receive ~$1.5 million related to the purchase by The Medicines Company of the shares of Incline common stock held by Cadence, subject to adjustment, and, potentially, a pro rata share of future milestone payments. The acquisition of Incline by The Medicines Company is subject to the satisfaction or waiver of customary closing conditions, and is currently expected to close in January, 2013.